By: Mahim Pretap Singh, published in ‘The Hindu’ 14 October 2010 Activists concerned over commercial ICMR investigations on side effects and ethical issues are still on. BHOPAL: The controversial anti-cervical cancer vaccines Gardasil and Cervarix, trials of which were suspended by the Indian government earlier this year, are slowly expanding their presence in Madhya Pradesh […]
Panel May Clear Cervical Cancer Vaccine Trials
By: Joe C. Mathew, New Delhi 28 September 2010 The three-member expert committee of the health ministry may give a clean chit to the agencies that conducted observational clinical trials on the safety and efficacy of cervical cancer vaccines marketed by global drug majors GlaxoSmithKline (GSK) and Merck in the country. The studies, independently initiated […]
Gardasil Research Targets Girls from Vulnerable Communities
By: N B Sarojini and Anjali Shenoi 12 September 2010 During July and August 2009, the Andhra Pradesh and Gujarat governments, in association with the Indian Council of Medical Research (ICMR) and the Program for Appropriate Technology in Health (PATH), launched what they described as a ‘demonstration project’ for vaccination against cervical cancer. Vaccines against […]
India poised to approve: Gardasil for Males to Fight Human Papillomavirus
Posted by: D V R Poosha, PhD in Abhisarika 12 September 2010 Gardasil vaccine, which is currently given to girls and young women to help prevent infection by four types of human papillomavirus, may be approved for boys as well, soon. An advisory committee from the Food and Drug Administration voted to recommend that the […]
RTI Act Not Applicable to HPV Vaccine
By: Arti Dhar, ‘The Hindu’ 09 August 2010 NEW DELHI: Information on the demonstration project and licensing of two vaccines to prevent cervical cancer has been exempted from public disclosure under Section 8 of the Right to Information Act, 2005. This is the reply received in response to an RTI application, submitted to the Union […]